ICLR
HealthcareICON Public Limited Company
$197.58
+$8.91 (+4.72%)
Jan 5, 2026
Price History (1Y)
Analysis
ICON Public Limited Company is a publicly traded company listed on the market with a sector classification in Healthcare and an industry specialization in Diagnostics & Research. The company has a substantial scale, with a market capitalization of $15.37 billion, annual revenue of $8.10 billion, and approximately 39,800 employees. From a financial health perspective, ICON's profitability indicators reveal a gross margin of 28.2%, operating margin of 12.7%, and profit margin of 7.4%. The company generates significant free cash flow of $925.35 million and maintains a substantial amount of cash on hand at $468.89 million, while carrying debt of $3.57 billion. Returns on equity and assets stand at 6.3% and 4.2%, respectively, indicating moderate profitability. Additionally, the company's current ratio is 1.06, suggesting relatively manageable liquidity. In terms of valuation context, ICON has a price-to-earnings (P/E) ratio of 25.46 (TTM) and 14.79 (forward), with an enterprise value to EBITDA multiple of 11.50. The company's revenue growth rate is 0.6% year-over-year, while earnings growth is -98.7%. Dividend information is not provided in the available facts section.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Visit website →Key Statistics
- Market Cap
- $15.37B
- P/E Ratio
- 25.46
- 52-Week High
- $228.29
- 52-Week Low
- $125.10
- Avg Volume
- 908.95K
- Beta
- 1.26
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NMS
- Country
- Ireland
- Employees
- 39,800